As of January 27, the global tally of SARS-CoV-2 infections has surpassed 100 million, with fatalities reaching 2 million. Remarkably, approximately 30 million confirmed cases remain untreated with ...

With the growing concern about the emergence of pandemics, such as the coronavirus disease 2019 (COVID-19) pandemic, drug development and repurposing are paramount. A recent study available on the ...

Wesley Greenblatt, Harvard University, Boston Children’s Hospital, and Massachusetts Institute of Technology, Boston, Massachusetts. Charu Gupta, University of California Los Angeles, Los Angeles, ...

Americans pay a lot of money for prescription medications. In 2023, spending on prescription drugs in the United States topped $722 billion, a trend that's expected to continue. Yet, nearly 30% ...

Finding a new medicine is never easy. But developing treatments for patients with rare diseases — conditions that afflict fewer than 200,000 people in the United States — is particularly challenging.

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. TxGNN is the first AI model specifically developed to identify ...

In a group of health-related headlines, one says "Hope for new drug approach. As government-supported research in the US is being decimated by funding cuts, it was refreshing to attend iDR25 (the ...

New Technologies Will Enable Every Cure to Bolster its Computational Drug Development, Drug Repurposing, and Clinical Trial Simulation Efforts – Uncovering More Approved Drugs to Treat Patients ...

Baritinib is a drug to treat rheumatoid arthritis. After outbreak of COVID-19, Benevolent AI Company discovered that AAK1 is a regulatory factor in the process of SARS-CoC-2 infection by generating a ...

PHILADELPHIA--(BUSINESS WIRE)--BioPhy, an innovative AI drug development company, today announced a partnership with Every Cure, a nonprofit initiative on a mission to unlock the full potential of ...